Stylage Bi-Soft XL (2x1ml)

Stylage XL utilizes a highly cross-linked HA matrix that acts as a structural scaffold for sagging tissues. The Mannitol serves as an antioxidant buffer, reducing post-filler swelling and extending longevity. Unlike superficial skin boosters, this product focuses on deep mechanical "lifting" power.

This treatment is strictly contraindicated. There is no clinical safety data regarding the use of high-density HA volumizers during pregnancy. We recommend postponing elective fillers until after childbirth and the cessation of breastfeeding.

The formulation contains 26 mg/ml of cross-linked Hyaluronic Acid and Mannitol as a protective antioxidant. This version does not contain Lidocaine.

Dosage is individualized based on the patient's existing volume deficit. Typically, 1 ml to 2 ml is used for bilateral cheek augmentation. Practitioners should evaluate if subtle structural support is achieved before utilizing the full density of Stylage XL for large-scale facial remodeling.

Expect minor temporary swelling, localized pressure, and potential purple bruising at the deep injection site. To ensure an optimal recovery, patients should follow our expert aftercare guide. Any persistent blanching must be evaluated immediately for vascular occlusion.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase blood flow to the injection site, potentially worsening swelling and increasing the risk of hematomas at the deep subcutaneous layers.

Injection is not recommended for nursing mothers. It is advised to postpone elective aesthetic procedures until the breastfeeding period has completely concluded to ensure maximum safety for both mother and infant.